ABYRAZ

Active ingredients

The drug ABYRAZ contains one active pharmaceutical ingredient (API):

UNII 82VFR53I78 - ARIPIPRAZOLE

It has been proposed that aripiprazole’s efficacy in schizophrenia and Bipolar I Disorder is mediated through a combination of partial agonism at dopamine D2 and serotonin 5-HT1A receptors and antagonism of serotonin 5-HT2A receptors.

Read about Aripiprazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Aripiprazole
N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX12

Authorization and marketing

This brand name is authorized in the following countries: Australia

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 8717T, 8718W, 8719X, 8720Y